Citadel Advisors’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.17M | Sell |
260,709
-20,309
| -7% | -$325K | ﹤0.01% | 2074 |
|
|
2025
Q1 | $5.46M | Sell |
281,018
-343,461
| -55% | -$6.67M | ﹤0.01% | 1678 |
|
|
2024
Q4 | $13.8M | Sell |
624,479
-219,174
| -26% | -$4.83M | ﹤0.01% | 1132 |
|
|
2024
Q3 | $14.2M | Buy |
843,653
+319,674
| +61% | +$5.38M | ﹤0.01% | 1053 |
|
|
2024
Q2 | $6.26M | Sell |
523,979
-178,683
| -25% | -$2.14M | ﹤0.01% | 1513 |
|
|
2024
Q1 | $7.79M | Buy |
702,662
+185,764
| +36% | +$2.06M | ﹤0.01% | 1450 |
|
|
2023
Q4 | $4.48M | Buy |
516,898
+329,109
| +175% | +$2.85M | ﹤0.01% | 1725 |
|
|
2023
Q3 | $1.44M | Sell |
187,789
-14,518
| -7% | -$111K | ﹤0.01% | 2694 |
|
|
2023
Q2 | $1.46M | Buy |
202,307
+54,361
| +37% | +$391K | ﹤0.01% | 2679 |
|
|
2023
Q1 | $901K | Buy |
147,946
+56,216
| +61% | +$342K | ﹤0.01% | 3280 |
|
|
2022
Q4 | $400K | Sell |
91,730
-32,076
| -26% | -$140K | ﹤0.01% | 4078 |
|
|
2022
Q3 | $486K | Sell |
123,806
-42,956
| -26% | -$169K | ﹤0.01% | 4107 |
|
|
2022
Q2 | $850K | Sell |
166,762
-3,491
| -2% | -$17.8K | ﹤0.01% | 3583 |
|
|
2022
Q1 | $1.09M | Buy |
170,253
+142,863
| +522% | +$915K | ﹤0.01% | 3649 |
|
|
2021
Q4 | $220K | Buy |
27,390
+6,470
| +31% | +$52K | ﹤0.01% | 5402 |
|
|
2021
Q3 | $194K | Buy |
+20,920
| New | +$194K | ﹤0.01% | 5445 |
|